Immunotherapy: OMNI-CAR, A UNIVERSAL CAR T CELL THERAPY UTILIZING COVALENT SPYTAG/SPYCATCHER BINDING TO TARGET MULTIPLE ANTIGENS IN DIFFERENT TUMORS
K. Sek, Phillip K. Darcy(Peter MacCallum Cancer Centre), Raymond J. Lim(University of California, Los Angeles), Junming Tong(The University of Melbourne), S. Yatomi-Clarke, Jason Li(Andover Eye Associates)
Cited by 1
Related Papers
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
|Nature Medicine|2010|338
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
|Cancer Cell|2023|218
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
|Nature Communications|2021|206